Entia Liberty®: Better care for your members, lower costs for you
With Liberty, members receiving cancer therapy are able to perform simple at-home blood tests in just 15 minutes, with 24/7 monitoring by a dedicated healthcare team.
There’s a problem in cancer care. And its costing health plans $11.79 billion a year.
Almost every health plan member going through systemic anti-cancer therapy is vulnerable to treatment complications. When these occur, the result is emergency room visits, hospitalizations and treatment disruptions. The most disruptive complication? Febrile Neutropenia [1].
The cost of Febrile Neutropenia
Febrile neutropenia is a common and serious complication of cancer therapy, presenting itself as a fever and a low white blood cell count.
The ever-present threat of febrile neutropenia makes life more difficult for your members, disrupting treatment and ultimately affecting survival.
The lack of insight into individuals' immunosuppression means many members at risk of febrile neutropenia have to make expensive emergency department visits, often unnecessarily. And this also means they miss out on personalized approaches to preventative medications that can help them avoid febrile neutropenia entirely.
The result? You’re spending up to $10,000 on avoidable costs for every member receiving an immunosuppressive treatment.
50%
$11.79 billion
of ER visits for fever could be safely managed from the patients home [3]
85%
of patients with febrile neutropenia never received preventative medications [2]
No. 1
Febrile neutropenia
=
$10,000
$4.3 billion
of avoidable costs for every member
[1] https://www.marketresearchfuture.com/reports/febrile-neutropenia-market-27190 [accessed 10th Sept 2025]
[2] Weycker, Derek, et al. "Use of colony-stimulating factor primary prophylaxis and incidence of febrile neutropenia from 2010 to 2016: a longitudinal assessment." Current Medical Research and Opinion
[3] Innes, Helen, et al. "Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice." Supportive Care in Cancer 16.5 (2008): 485-491 ; [2] Data on file - real world evidence and EMT Study
No. 2
Acute Kidney Injury
$1.0 billion
No. 3
Anaemia
Introducing Entia Liberty®
24/7 at-home blood monitoring service for cancer patients
Entia Liberty® Analyzer
Simple self-testing from the comfort of home
Results in 15 minutes
Protected by 68 patents
The Liberty Analyzer is not cleared by the FDA
24/7 Healthcare Monitoring
Blood results go straight to healthcare professionals for 24/7 monitoring
National coverage from oncology specialists
Why offer Liberty as part of your health plan?
Address avoidable ED visits
Liberty enables regular blood monitoring at home, supporting healthcare teams in their assessment of febrile neutropenia risk and allowing for more appropriate triaging.
Significant savings per member
Better triaging reduces unnecessary trips to the ED and hospitalizations, lowering costs and keeping them more predictable. This frees you up to invest in the care pathways that help more of your members.
A personalized approach to care
More data from regular blood monitoring supports members in making personalized day-to-day decisions that may help avoid c or delays to their treatment.
Attract and retain members
With better healthcare and a better treatment experience, you’ll retain more members. And with a strong reputation for excellent, preventative healthcare, you’ll attract more members too.
“When Liberty was introduced into my treatment journey, it made it even easier to manage my health. It’s not just about ease; it’s about feeling like you’re in control of a situation that is often unpredictable.”
Angela, Breast Cancer Patient
How it works
Liberty is more than a blood analyzer. It’s an end-to-end blood monitoring service that’s simple to scale. We handle all aspects of the service and logistics, so you and your members can enjoy the benefits.
1. Enrollment
Patient is enrolled onto Liberty by the health plan
2. Shipping
We ship all equipment directly to the patient
3. Training
We ensure the patient is confident with self-testing
4. Monitoring
Patients results are monitored by a healthcare team
5. Collection
We collect everything directly from the patient’s home
“Personalizing the use of G-CSF with at-home blood count monitoring is a major opportunity to further reduce the incidence of febrile neutropenia in cancer patients.”
Prof. Hope Rugo, M.D.
Professor, Medical Oncology and Therapeutics Research, City of Hope
“Blood monitoring in the home presents new opportunities to significantly improve patient triaging and subsequently reduce the burden of ED visits.”
Prof. Adam Brufsky, M.D.
Professor of Medicine & Associate Chief, Division of Hematology/ Oncology, University of Pittsburgh.
PROTECT your members. Sign up and see the impact with exclusive early access.
Join PROTECT, an observational study of 300 patients using Liberty over ~3 months. By signing up, you’ll:
Get early access to Liberty so you can quantify the impact it can have on your members
Be a priority partner with immediate access to Liberty as soon as it’s available for broader use, putting you ahead of other health plans
Retain and attract more members by offering the latest advances in healthcare
Together, we can change cancer care for the better.